|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 38/17 | (2006.01) | ||
| A61K 47/22 | (2006.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 9/08 | (2006.01) |
| (11) | Number of the document | 4364724 |
| (13) | Kind of document | T |
| (96) | European patent application number | 24156902.9 |
| Date of filing the European patent application | 2019-05-10 | |
| (97) | Date of publication of the European application | 2024-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2025-11-26 |
| (46) | Date of publication of the claims translation | 2026-01-12 |
| (30) | Number | Date | Country code |
| 201862669506 P | 2018-05-10 | US | |
| 201862752127 P | 2018-10-29 | US | |
| 201862769876 P | 2018-11-20 | US | |
| 201962813882 P | 2019-03-05 | US |
| (72) |
GRAHAM, Kenneth S. , US
WADHWA, Saurabh , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinės formos, kurių sudėtyje yra didelės koncentracijos VEGF receptoriaus sulietas baltymas |
| HIGH CONCENTRATION VEGF RECEPTOR FUSION PROTEIN CONTAINING FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2026-04-21 | 8 | 185.00 EUR |
| 2027-05-10 |